1. Home
  2. XNET vs SCTX Comparison

XNET vs SCTX Comparison

Compare XNET & SCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xunlei Limited

XNET

Xunlei Limited

N/A

Current Price

$3.48

Market Cap

319.3M

Sector

Technology

ML Signal

N/A

Logo Scribe Therapeutics Inc. Common Stock

SCTX

Scribe Therapeutics Inc. Common Stock

N/A

Current Price

$15.98

Market Cap

297.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
XNET
SCTX
Founded
2003
2017
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
319.3M
297.2M
IPO Year
2011
2026

Fundamental Metrics

Financial Performance
Metric
XNET
SCTX
Price
$3.48
$15.98
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $57.00
AVG Volume (30 Days)
272.9K
★ 360.7K
Earning Date
11-12-2026
11-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.29
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.10
$13.50
52 Week High
$8.80
$39.60

Technical Indicators

Market Signals
Indicator
XNET
SCTX
Relative Strength Index (RSI) 33.26 41.34
Support Level N/A $13.90
Resistance Level $6.10 $22.07
Average True Range (ATR) 0.21 1.84
MACD -0.01 0.16
Stochastic Oscillator 39.36 27.20

Price Performance

Historical Comparison
XNET
SCTX

About XNET Xunlei Limited

Xunlei Ltd is a technology company providing distributed cloud services in China. It operates a powerful internet platform in China based on cloud technology to enable its users to quickly access, store, manage and consume digital media content on the internet. The company has expanded its products and services from PC-based devices to mobile devices in part through pre-installed acceleration products in mobile phones to further enlarge its user base and offer its users a wider range of access points. It provides a wide range of products and services across cloud acceleration and digital entertainment to deliver an efficient, smart and safe internet environment to its users.

About SCTX Scribe Therapeutics Inc. Common Stock

Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.

Share on Social Networks: